Penumbra, Inc.
PENNYSEHealthcare● Active
$320.49
$-0.04(-0.01%)
Market Cap$12.6B
P/E Ratio—
52W High$362.41
52W Low$221.26
Penumbra, Inc. (PEN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PEN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 6, 2026EPS Actual
$0.82
Est. $1.04 · -21.1%
Revenue
$0.37B
Est. $0.37B · +1.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 6, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
PEN reports quarterly as a NYSE-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $1.18 | — | — | — | $0.39B | — |
| ▼ Q2 FY2026 | May 6, 2026 | $1.04 | $0.82 | -21.1% | $0.37B | $0.37B | +1.2% |
| ▲ Q1 FY2026 | Feb 25, 2026 | $1.11 | $1.18 | +6.3% | $0.39B | $0.36B | +6.5% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $0.93 | $0.97 | +4.4% | $0.35B | $0.34B | +4.0% |
| ▲ Q3 FY2025 | Jul 29, 2025 | $0.81 | $0.86 | +6.2% | $0.34B | $0.34B | -0.6% |
| ▲ Q2 FY2025 | Apr 23, 2025 | $0.66 | $0.83 | +25.8% | $0.32B | $0.33B | -1.0% |
| ▲ Q1 FY2025 | Feb 18, 2025 | $0.88 | $0.97 | +10.2% | $0.32B | $0.31B | +1.3% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $0.69 | $0.85 | +23.2% | $0.30B | $0.31B | -3.4% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$1.18
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 6, 2026Miss
EPS Actual
$0.82
EPS Est.
$1.04
EPS Surpr.
-21.1%
Revenue
$0.37B
Q1 FY2026
Feb 25, 2026Beat
EPS Actual
$1.18
EPS Est.
$1.11
EPS Surpr.
+6.3%
Revenue
$0.39B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$0.97
EPS Est.
$0.93
EPS Surpr.
+4.4%
Revenue
$0.35B
Q3 FY2025
Jul 29, 2025Beat
EPS Actual
$0.86
EPS Est.
$0.81
EPS Surpr.
+6.2%
Revenue
$0.34B
Q2 FY2025
Apr 23, 2025Beat
EPS Actual
$0.83
EPS Est.
$0.66
EPS Surpr.
+25.8%
Revenue
$0.32B
Q1 FY2025
Feb 18, 2025Beat
EPS Actual
$0.97
EPS Est.
$0.88
EPS Surpr.
+10.2%
Revenue
$0.32B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$0.85
EPS Est.
$0.69
EPS Surpr.
+23.2%
Revenue
$0.30B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.95 | $1.98 | $2.00 | 5 |
| Q3 FY2028 | $1.92 | $1.95 | $1.98 | 5 |
| Q2 FY2028 | $1.79 | $1.82 | $1.85 | 6 |
| Q1 FY2028 | $1.47 | $1.50 | $1.52 | 3 |
| Q4 FY2027 | $1.74 | $1.76 | $1.79 | 2 |
| Q3 FY2027 | $1.57 | $1.59 | $1.61 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.5B | $0.5B | $0.5B | 2 |
| Q3 FY2028 | $0.5B | $0.5B | $0.5B | 2 |
| Q2 FY2028 | $0.5B | $0.5B | $0.5B | 2 |
| Q1 FY2028 | $0.5B | $0.5B | $0.5B | 2 |
| Q4 FY2027 | $0.5B | $0.5B | $0.5B | 3 |
| Q3 FY2027 | $0.4B | $0.5B | $0.5B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 6, 2026 | -21.1% | $323.86 | $324.19 | +0.10% |
| ▲ Q1 FY2026 | Feb 25, 2026 | +6.3% | $339.59 | $338.67 | -0.27% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +4.4% | $235.08 | $225.54 | -4.06% |
| ▲ Q3 FY2025 | Jul 29, 2025 | +6.2% | $230.17 | $227.15 | -1.31% |
| ▲ Q2 FY2025 | Apr 23, 2025 | +25.8% | $277.22 | $278.77 | +0.56% |
| ▲ Q1 FY2025 | Feb 18, 2025 | +10.2% | $268.67 | $271.14 | +0.92% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +23.2% | $209.63 | $211.29 | +0.79% |
| ▲ Q3 FY2024 | Jul 30, 2024 | +14.3% | $178.38 | $173.09 | -2.97% |
Q2 FY2026+0.10%
Report Date
May 6, 2026
EPS Beat/Miss
-21.1%
Price Before
$323.86
Price After
$324.19
Q1 FY2026-0.27%
Report Date
Feb 25, 2026
EPS Beat/Miss
+6.3%
Price Before
$339.59
Price After
$338.67
Q4 FY2025-4.06%
Report Date
Nov 5, 2025
EPS Beat/Miss
+4.4%
Price Before
$235.08
Price After
$225.54
Q3 FY2025-1.31%
Report Date
Jul 29, 2025
EPS Beat/Miss
+6.2%
Price Before
$230.17
Price After
$227.15
Q2 FY2025+0.56%
Report Date
Apr 23, 2025
EPS Beat/Miss
+25.8%
Price Before
$277.22
Price After
$278.77
Q1 FY2025+0.92%
Report Date
Feb 18, 2025
EPS Beat/Miss
+10.2%
Price Before
$268.67
Price After
$271.14
Q4 FY2024+0.79%
Report Date
Oct 30, 2024
EPS Beat/Miss
+23.2%
Price Before
$209.63
Price After
$211.29
Q3 FY2024-2.97%
Report Date
Jul 30, 2024
EPS Beat/Miss
+14.3%
Price Before
$178.38
Price After
$173.09
Avg Beat Reaction-0.91%
Avg Miss Reaction+0.10%
Beat Rate7 / 8 quarters
Largest Move-4.06% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PEN ends December
Penumbra, Inc. (PEN) most recently reported earnings on May 6, 2026 for Q2 FY2026, posting EPS of $0.82 — missing the analyst consensus of $1.04 by -21.1%. The next PEN earnings date is expected around September 1, 2026.
Each quarter, investors track PEN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PEN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PEN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PEN earnings · 5 questionsPenumbra, Inc.'s next earnings report is expected around September 1, 2026. PEN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PEN historically reports after market close (AMC).
PEN earnings datewhen is PEN earningsPEN next earnings datewhen does PEN report earningsPEN earnings calendar
▸ Source: FMP · Penumbra, Inc. SEC filings · US GAAP · Penumbra, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026